EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C41H52N4O4S |
| Net Charge | 0 |
| Average Mass | 696.958 |
| Monoisotopic Mass | 696.37093 |
| SMILES | CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@](=O)Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1 |
| InChI | InChI=1S/C41H52N4O4S/c1-5-7-22-48-23-24-49-38-15-10-32(11-16-38)33-12-19-40-35(25-33)26-34(9-8-21-44(40)28-31(3)4)41(46)43-36-13-17-39(18-14-36)50(47)29-37-27-42-30-45(37)20-6-2/h10-19,25-27,30-31H,5-9,20-24,28-29H2,1-4H3,(H,43,46)/b34-26+/t50-/m0/s1 |
| InChIKey | PNDKCRDVVKJPKG-WHERJAGFSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | chemokine receptor 2 antagonist An antogonist that blocks chemokine receptor 2 (CCR2). anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. chemokine receptor 5 antagonist An antogonist that blocks chemokine receptor 5 (CCR5). |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. antirheumatic drug A drug used to treat rheumatoid arthritis. antifibrotic agent Any agent which acts to reduce fibrosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| cenicriviroc (CHEBI:149636) has role anti-HIV agent (CHEBI:64946) |
| cenicriviroc (CHEBI:149636) has role anti-inflammatory agent (CHEBI:67079) |
| cenicriviroc (CHEBI:149636) has role antifibrotic agent (CHEBI:233423) |
| cenicriviroc (CHEBI:149636) has role antirheumatic drug (CHEBI:35842) |
| cenicriviroc (CHEBI:149636) has role chemokine receptor 2 antagonist (CHEBI:149711) |
| cenicriviroc (CHEBI:149636) has role chemokine receptor 5 antagonist (CHEBI:63673) |
| cenicriviroc (CHEBI:149636) is a aromatic ether (CHEBI:35618) |
| cenicriviroc (CHEBI:149636) is a benzazocine (CHEBI:39307) |
| cenicriviroc (CHEBI:149636) is a diether (CHEBI:46786) |
| cenicriviroc (CHEBI:149636) is a imidazoles (CHEBI:24780) |
| cenicriviroc (CHEBI:149636) is a secondary carboxamide (CHEBI:140325) |
| cenicriviroc (CHEBI:149636) is a sulfoxide (CHEBI:22063) |
| IUPAC Name |
|---|
| (5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-(4-{(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl}phenyl)-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide |
| INNs | Source |
|---|---|
| cenicriviroc | WHO MedNet |
| cenicrivirocum | WHO MedNet |
| cenicriviroc | WHO MedNet |
| cénicriviroc | WHO MedNet |
| Synonyms | Source |
|---|---|
| TAK-652 | ChemIDplus |
| TBR-652 | ChemIDplus |
| CVC | ChemIDplus |
| TBR 652 | DrugBank |
| Manual Xrefs | Databases |
|---|---|
| Cenicriviroc | Wikipedia |
| DB11758 | DrugBank |
| D09878 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:497223-25-3 | ChemIDplus |
| Citations |
|---|